down arrow

SI-BONE, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8257041090
USD
19.24
-0.18 (-0.93%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
MiMedx Group, Inc.
LeMaitre Vascular, Inc.
Stevanato Group SpA
SI-BONE, Inc.
Paragon 28, Inc.
Establishment Labs Holdings, Inc.
Tandem Diabetes Care, Inc.
Avanos Medical, Inc.
Myriad Genetics, Inc.
Quanterix Corp.
Owens & Minor, Inc.
Why is SI-BONE, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate 4.85% of over the last 5 years
2
The company has declared Positive results for the last 9 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD -3.26 MM
  • NET PROFIT(HY) Higher at USD -12.69 MM
  • ROCE(HY) Highest at -14.18%
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 55.49%, its profits have risen by 38.4%
4
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Market Beating Performance
  • The stock has generated a return of 55.49% in the last 1 year, much higher than market (S&P 500) returns of 12.33%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to SI-BONE, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is SI-BONE, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
SI-BONE, Inc.
47.77%
0.96
51.75%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
22.61%
EBIT Growth (5y)
4.85%
EBIT to Interest (avg)
-13.19
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.64
Sales to Capital Employed (avg)
0.76
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.82
EV to EBIT
-22.73
EV to EBITDA
-26.71
EV to Capital Employed
11.74
EV to Sales
3.95
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-51.64%
ROE (Latest)
-15.87%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -3.26 MM

NET PROFIT(HY)

Higher at USD -12.69 MM

ROCE(HY)

Highest at -14.18%

RAW MATERIAL COST(Y)

Fallen by -1.03% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 7.43 times

-1What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at -63.76 %

Here's what is working for SI-BONE, Inc.
Operating Cash Flow
Highest at USD -3.26 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit
Higher at USD -12.69 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Debtors Turnover Ratio
Highest at 7.43 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -1.03% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 1.37 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for SI-BONE, Inc.
Debt-Equity Ratio
Highest at -63.76 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."